Recent Quarter Total Invested
$242.46 M
Recent Quarter Institutional Ownership Percentage
43.68%
Total Invested of Last Quarter
$272.34 M
Ownership Percentage of Last Quarter
52.28%
TScan Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LYNX1 CAPITAL MANAGEMENT LP | 08/14/2024 | 5.22 M | $30.56 M | 0.00% | 5.51% |
ECOR1 CAPITAL, LLC | 08/14/2024 | 5.00 M | $29.25 M | 0.00% | 5.27% |
BLACKROCK INC. | 08/13/2024 | 4.46 M | $26.10 M | 162.61% | 4.70% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 4.40 M | $25.74 M | 12.82% | 4.64% |
BVF INC/IL | 08/14/2024 | 2.99 M | $17.49 M | 0.00% | 3.15% |
BAKER BROS. ADVISORS LP | 08/14/2024 | 2.78 M | $16.29 M | 0.00% | 2.94% |
VANGUARD GROUP INC | 08/13/2024 | 2.13 M | $12.48 M | 18.00% | 2.25% |
PROPEL BIO MANAGEMENT, LLC | 08/12/2024 | 2.09 M | $12.21 M | 0.00% | 2.20% |
DEER MANAGEMENT CO. LLC | 08/14/2024 | 1.25 M | $7.29 M | 0.00% | 1.31% |
ALPHABET INC. | 08/02/2024 | 1.08 M | $6.30 M | 0.00% | 1.14% |
SIMPLIFY ASSET MANAGEMENT INC. | 08/12/2024 | 1.05 M | $6.12 M | 0.00% | 1.10% |
GREAT POINT PARTNERS LLC | 08/14/2024 | 940,831 | $5.50 M | 100.00% | 0.99% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 900,499 | $5.27 M | 117.63% | 0.95% |
STEMPOINT CAPITAL LP | 08/13/2024 | 845,069 | $4.94 M | 100.00% | 0.89% |
LMR PARTNERS LLP | 08/14/2024 | 665,529 | $3.89 M | 100.00% | 0.70% |
DC FUNDS, LP | 08/13/2024 | 630,000 | $3.69 M | 0.00% | 0.66% |
STATE STREET CORP | 08/14/2024 | 608,085 | $3.56 M | 350.43% | 0.64% |
INVESCO LTD. | 08/13/2024 | 499,874 | $2.92 M | 2.35% | 0.53% |
PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 353,886 | $2.07 M | 100.00% | 0.37% |
MARSHALL WACE, LLP | 08/14/2024 | 307,487 | $1.80 M | 60.84% | 0.32% |
ABRDN PLC | 08/09/2024 | 292,144 | $1.71 M | 46.07% | 0.31% |
MORGAN STANLEY | 10/17/2024 | 241,672 | $1.41 M | 7.94% | 0.25% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 08/12/2024 | 209,830 | $1.23 M | -1.12% | 0.22% |
WOODLINE PARTNERS LP | 08/14/2024 | 163,492 | $956,428 | 100.00% | 0.17% |
CITADEL ADVISORS LLC | 08/14/2024 | 157,963 | $924,083 | 1,281.76% | 0.17% |
ALPINE GLOBAL MANAGEMENT, LLC | 08/14/2024 | 137,490 | $804,317 | 100.00% | 0.14% |
BANK OF MONTREAL /CAN/ | 08/14/2024 | 120,454 | $749,224 | 100.00% | 0.13% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 116,658 | $682,449 | 100.00% | 0.12% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 112,941 | $660,705 | 410.95% | 0.12% |
WALLEYE CAPITAL LLC | 08/14/2024 | 107,665 | $629,840 | 105.16% | 0.11% |
JANE STREET GROUP, LLC | 08/15/2024 | 99,036 | $579,360 | -35.33% | 0.10% |
NORTHERN TRUST CORP | 08/14/2024 | 97,512 | $570,445 | 26.70% | 0.10% |
STIFEL FINANCIAL CORP | 08/13/2024 | 95,400 | $558,090 | -5.92% | 0.10% |
TROLUCE CAPITAL ADVISORS LLC | 08/14/2024 | 92,832 | $543,067 | 100.00% | 0.10% |
NEWEDGE WEALTH, LLC | 08/02/2024 | 91,463 | $535,059 | 0.00% | 0.10% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 90,941 | $532,005 | 100.00% | 0.10% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 80,000 | $468,000 | 70.21% | 0.08% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 78,385 | $458,552 | -45.39% | 0.08% |
BROWN BROTHERS HARRIMAN & CO | 08/09/2024 | 76,024 | $444,740 | 100.00% | 0.08% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 69,962 | $409,277 | 100.00% | 0.07% |
LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 60,400 | $353,340 | -83.34% | 0.06% |
AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 47,481 | $277,764 | 48.91% | 0.05% |
RHUMBLINE ADVISERS | 08/01/2024 | 46,867 | $274,164 | 100.00% | 0.05% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 43,782 | $256,124 | 45.07% | 0.05% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 38,300 | $224,055 | -39.49% | 0.04% |
DC INVESTMENTS MANAGEMENT, LLC | 08/13/2024 | 35,563 | $208,044 | 0.00% | 0.04% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 35,268 | $206,318 | -86.44% | 0.04% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 27,889 | $163,151 | -92.89% | 0.03% |
CORNERCAP INVESTMENT COUNSEL INC | 08/08/2024 | 22,940 | $134,199 | 100.00% | 0.02% |
PALE FIRE CAPITAL SE | 08/13/2024 | 21,573 | $126,202 | 0.00% | 0.02% |
TScan Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of TCRX shares?
During the previous two years, 91 institutional investors and hedge funds held shares of TScan Therapeutics, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 5.22 M
EcoR1 Capital, LLC: 5 M
BlackRock Inc.: 4.46 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.4 M
BVF INC/IL: 2.99 M
BAKER BROS. ADVISORS LP: 2.78 M
-
What percentage of TScan Therapeutics, Inc. stock is owned by institutional investors?
43.68% of TScan Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at TCRX ?
Institutional investors have bought a total of 42.57 M shares in the last 24 months. This purchase volume represents approximately $210.71 M in transactions.